Adenosine

ABL proto-oncogene 1, non-receptor tyrosine kinase ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35021069 Development of asciminib, a novel allosteric inhibitor of BCR-ABL1. 2022 Mar 1
2 33736651 Third-line therapy for chronic myeloid leukemia: current status and future directions. 2021 Mar 18 2
3 14635203 Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis. 2003 Dec 1